MoonLake Immunotherapeuti... (MLTX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
44.82
-0.07 (-0.16%)
At close: Jan 28, 2025, 1:52 PM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | 13.16K | 12.36K | 4.97K | n/a |
Gross Profit | -13.16K | -12.36K | -4.97K | n/a |
Operating Income | -54.12M | -65.06M | -53.58M | -105.76K |
Interest Income | n/a | n/a | n/a | 14.92K |
Pretax Income | -43.98M | -64.47M | -53.64M | -90.84K |
Net Income | -36.01M | -64.51M | -53.64M | -90.84K |
Selling & General & Admin | 22.32M | 23.01M | 18.05M | 105.75K |
Research & Development | 31.79M | 42.05M | 35.52M | n/a |
Other Expenses | n/a | 591.73K | n/a | n/a |
Operating Expenses | 54.12M | 65.06M | 53.57M | 105.75K |
Interest Expense | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | 18.03M | n/a |
Cost & Expenses | 54.12M | 65.06M | 53.58M | 105.75K |
Income Tax | 94.39K | 36.37K | 4.75K | -206.30K |
Shares Outstanding (Basic) | 49.12M | 29.36M | 7.84M | 14.80M |
Shares Outstanding (Diluted) | 49.12M | 29.36M | 7.84M | 14.80M |
EPS (Basic) | -0.73 | -2.2 | -6.84 | -0.01 |
EPS (Diluted) | -0.73 | -2.2 | -6.84 | -0.01 |
EBITDA | -54.11M | -65.05M | -53.63M | -90.84K |
Depreciation & Amortization | 13.16K | 12.36K | 4.97K | 206.30K |